Emergent BioSolutions (EBS) Tops Q4 EPS by 23c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.80 -3.13%
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -138.7%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $4.50, $0.23 better than the analyst estimate of $4.27. Revenue for the quarter came in at $723.2 million versus the consensus estimate of $691.36 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Redburn upgrades Southwest, stays bullish on Delta and United
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
